Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Protein Variants

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 132 > >>
EC Number Protein Variants Commentary Reference
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4A1444G substitution located in exon 13 leading to 20% of wild type activity 673943
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4A181V the mutant is not inhibited by N-(2,4-dichlorophenethyl)-2-[8-(2,4-dimethoxybenzoyl)-4-oxo-1-phenyl-1,3,8-triazaspiro-[4.5]decan-3-yl]acetamid compared to the wild type enzyme -, 711225
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4A290R the mutant is less sensitive to N-(2,4-dichlorophenethyl)-2-[8-(2,4-dimethoxybenzoyl)-4-oxo-1-phenyl-1,3,8-triazaspiro-[4.5]decan-3-yl]acetamid than the wild type enzyme -, 711225
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4A328V site-directed mutagenesis of the conserved residue, the site-specific dihydrolipoamide dehydrogenase mutant shows a switched kinetic mechanism, it shows a random sequential kinetic mechanism with an interaction factor (alpha) of 8.5. The mutation deteriorates substantially the catalytic power of human E3 enzyme increasing the binding affinity for NAD+ and dihydrolipoamide . The mutation triggers this potential intrinsic property of the enzyme causing the kinetic mechanism of the mutant to switch from a ping-pong mechanism to a random sequential mechanism 742221
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4A48I the mutation decreases the Km for dihydrolipoamide substrate by 3fold compared to the wild type enzyme 764880
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4A54I the mutation increases the Km for dihydrolipoamide substrate by 1fold and NAD+ by 3fold compared to the wild type enzyme 764880
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4C15T the mutation increases the Km for dihydrolipoamide substrate by 5fold and NAD+ by 3fold compared to the wild type enzyme 764880
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4C38G the mutation increases the Km for NAD+ by 9fold without affecting Km for dihydrolipoamide compared to the wild type enzyme 764880
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4C44S 0.003% of the activity of wild-type enzyme with NAD+ and dihydrolipoamide. Enzyme is capable to catalyze reactions with NADH as electron donor and ferricyanide, thio-NAD+, 2,6-dichlorophenol indophenol and O2 as electron acceptor. The fluorescence of FAD in oxidized wild-type enzyme is markedly temperature dependent, while the fluorescence of FAD in mutants C44S and C49S is independent of temperature 393989
Show all pathways known for 1.8.1.4Display the word mapDisplay the reaction diagram Show all sequences 1.8.1.4C45S Ser-45 mutant is highly purified, shows 5270fold lower activity than wild-type enzyme. Destroyed disulfide bond between Cys-45 and Cys-50 of the active disulfide center in human E3. UV-visible spectrum of the Ser-45 mutant is similar to that of the reduced form of the enzyme and the second fluorescence emission of the mutant disappears 691569
Results 1 - 10 of 132 > >>